Estimating Alzheimer's disease causative genes by an evolutionary medicine approach

Alzheimer's disease patients are increasing with the aging of the world's population, becoming a huge health care and social burden. To find the cause of various diseases, in recent years, scientists have focused within the human genome on copy number variations (CNVs), which are changes in the number of genes within a population.

Likewise, a group of genes responsible for a gene number change has also been reported for Alzheimer's disease, but to date, it has not been easy to identify a causative gene from within the pathogenic CNV region.

Now, a new approach to finding Alzheimer's disease (AD) causative genes was estimated by paying attention to special duplicated genes called "ohnologs" included in the genomic region specific to AD patients. Human ohnologs, which are vulnerable to change in number, were generated by whole 500 million years ago.

In a new study published in the advanced online edition of Molecular Biology and Evolution, Mizuka Sekine and Takashi Makino investigated the and knockout mouse phenotype for ohnologs, and succeeded in narrowing down the genetic culprits. The narrowed gene group had a function related to the nervous system and a high expression level in the brain which were similar to characteristics of known AD causative genes.

Their findings suggest that the identification of causative genes using ohnologs is a promising and effective approach in diseases caused by dosage change.


Explore further

Characterizing the mouse genome reveals new gene functions and their role in human disease

More information: Molecular Biology And Evolution (2017). DOI: 10.1093/molbev/msx183
Journal information: Molecular Biology and Evolution

Citation: Estimating Alzheimer's disease causative genes by an evolutionary medicine approach (2017, June 27) retrieved 14 November 2019 from https://medicalxpress.com/news/2017-06-alzheimer-disease-genes-evolutionary-medicine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments